Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.080
-0.020 (-0.95%)
At close: Oct 30, 2026, 4:00 PM EDT
2.100
+0.020 (0.96%)
After-hours: Oct 30, 2026, 7:50 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $93.21 million as of October 30, 2026. It is the 25,483rd most valuable company in the world and the 4,128th biggest in the United States. Its market cap has decreased by 67.58% in one year.
Market Cap
93.21M
Enterprise Value
76.96M
1-Year Change
-67.58%
Global Rank
Country Rank
#4,128 United States
Category
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $93.21M, a decrease of -34.22%. That is a compound annual growth rate of -10.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 93.21M | -43.17% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 101.94M |
| ProMIS Neurosciences | 99.36M |
| Retension Pharmaceuticals | 98.56M |
| Tevogen | 95.21M |
| NeurAxis | 94.81M |
| ImmuCell | 93.73M |
| Coya Therapeutics | 93.36M |
| Polaryx Therapeutics | 92.71M |